Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2015-08-06

FDA Approved: VARITHENA — Supplemental Application (Biocompatibles, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Varithena (polidocanol) by Biocompatibles, Inc. This action approves changes to the product’s labeling under the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varithena (polidocanol injectable foam)

Snippet

SUPPL AP for VARITHENA (POLIDOCANOL)